Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease
- PMID: 20398589
- PMCID: PMC4550292
Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease
Abstract
Despite the overall success in the fight against viral hepatitis, there remain racial, ethnic, and socioeconomic disparities in the incidence and prevalence of acute and chronic viral hepatitis, the outcomes of chronic viral hepatitis, and health care access and quality. Numerous federal and community initiatives are aimed at overcoming these discrepancies.
Figures
Similar articles
-
Viral hepatitis and hepatocellular carcinoma in African Americans.Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):248s-251s. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646520 No abstract available.
-
The Role of Culturally Appropriate Mediated Communication Strategies to Reduce Hepatitis B and Liver Cancer Disparities.J Health Commun. 2024 Jul 2;29(7):440-449. doi: 10.1080/10810730.2024.2362882. Epub 2024 Jun 4. J Health Commun. 2024. PMID: 38832597
-
Recommendations for prevention, screening, and diagnosis of HBV and HCV infections.J Fam Pract. 2010 Apr;59(4 Suppl):S29-35. J Fam Pract. 2010. PMID: 20398588 No abstract available.
-
Promoting prevention of viral hepatitis in the African American community.J Natl Med Assoc. 2003 Apr;95(4 Suppl):49S-56S. J Natl Med Assoc. 2003. PMID: 12749609 Free PMC article. Review. No abstract available.
-
Prevention and treatment of hepatocellular carcinoma.Liver Transpl. 2004 Feb;10(2 Suppl 1):S111-4. doi: 10.1002/lt.20046. Liver Transpl. 2004. PMID: 14762850 Review.
Cited by
-
Vaccination in Patients with Liver Cirrhosis: A Neglected Topic.Vaccines (Basel). 2024 Jun 27;12(7):715. doi: 10.3390/vaccines12070715. Vaccines (Basel). 2024. PMID: 39066353 Free PMC article. Review.
-
Vaccination Campaign against Hepatitis B Virus in Italy: A History of Successful Achievements.Vaccines (Basel). 2023 Sep 27;11(10):1531. doi: 10.3390/vaccines11101531. Vaccines (Basel). 2023. PMID: 37896935 Free PMC article. Review.
-
Infectious diseases in Indigenous populations in North America: learning from the past to create a more equitable future.Lancet Infect Dis. 2023 Oct;23(10):e431-e444. doi: 10.1016/S1473-3099(23)00190-1. Epub 2023 May 3. Lancet Infect Dis. 2023. PMID: 37148904 Free PMC article. Review.
-
Viral Hepatitis Among African Immigrants with Hepatocellular Carcinoma in Minnesota: High Prevalence Yet Low Awareness.J Immigr Minor Health. 2023 Apr;25(2):357-364. doi: 10.1007/s10903-022-01400-1. Epub 2022 Sep 15. J Immigr Minor Health. 2023. PMID: 36109400
-
Race and ethnicity do not impact eligibility for remdesivir: A single-center experience.PLoS One. 2021 May 6;16(5):e0250735. doi: 10.1371/journal.pone.0250735. eCollection 2021. PLoS One. 2021. PMID: 33956849 Free PMC article. Clinical Trial.
References
-
- Rawls RA, Vega KJ. Viral hepatitis in minority America. J Clin Gastroenterol. 2005;39:144–151. - PubMed
-
- Hall-Baker CA, Nieves E Jr, Jajosky RA, et al. Centers for Disease Control and Prevention. Summary of notifiable diseases—United States, 2007. MMWR. 2009;56:1–94.
-
- Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–714. - PubMed
-
- Centers for Disease Control and Prevention. National Center for Health Statistics. Health, United States, 2009. Available at: http://www.cdc.gov/nchs/hus.htm. Accessed December 8, 2009.
-
- Wise M, Bialek S, Finelli L, et al. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology. 2008;47:1128–1135. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical